Kamada (KMDA) Change in Working Capital (2020 - 2026)
Kamada (KMDA) reported Change in Working Capital of -$12.1 million for Q1 2026, up 2.5% on a YoY basis from -$11.8 million in Q1 2025, and down 2414.52% quarter-over-quarter from -$482000.0 in Q4 2025.
Kamada (KMDA) Change in Working Capital (2020 - 2026) Analysis & Trends
Kamada has reported Change in Working Capital for 7 years, with the latest figure at -$12.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Working Capital rose 2.5% year-over-year to -$12.1 million; the trailing twelve-month figure through Mar 2026 stood at -$17.4 million (down 410.03% YoY), and the FY2025 full-year result was -$17.7 million, down 254.93% from the prior year.
- Change in Working Capital for Q1 2026 stood at -$12.1 million, down from -$482000.0 in the prior quarter.
- The five-year high for Change in Working Capital was $13.0 million in Q3 2024, with the low at -$12.4 million in Q1 2025.
- Historically, Change in Working Capital has averaged -$377208.7 across 5 years, with a median of -$482000.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Working Capital jumped 423.97% — and 2023, when it sank 2048944.59%.
- Kamada's Change in Working Capital stood at $11.6 million in 2022, then plunged by 115.06% to -$1.8 million in 2023, then soared by 126.66% to $467000.0 in 2024, then slumped by 203.21% to -$482000.0 in 2025, then slumped by 2414.52% to -$12.1 million in 2026.
- The last three Change in Working Capital figures came in at -$12.1 million (Q1 2026), -$482000.0 (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -617.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 215.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | -12.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.12 Mn |
| Mar 31, 2026 | -12.12 Mn |
| Dec 31, 2025 | -482,000.00 |
| Dec 31, 2025 | -482,000.00 |
| Sep 30, 2025 | -1.55 Mn |
| Sep 30, 2025 | -1.55 Mn |
| Jun 30, 2025 | -3.22 Mn |
| Jun 30, 2025 | -3.22 Mn |
| Mar 31, 2025 | -12.43 Mn |
| Mar 31, 2025 | -12.43 Mn |
| Dec 31, 2024 | 467,000.00 |
| Dec 31, 2024 | 467,000.00 |
| Sep 30, 2024 | 13.01 Mn |
| Sep 30, 2024 | 13.01 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | -6.62 Mn |
| Mar 31, 2024 | -6.62 Mn |
| Dec 31, 2023 | -1.75 Mn |
| Dec 31, 2023 | -1.75 Mn |